Bessemer Group Inc. reduced its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 19.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,900 shares of the company’s stock after selling 3,200 shares during the period. Bessemer Group Inc.’s holdings in USANA Health Sciences were worth $955,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the business. First Quadrant L P CA boosted its position in shares of USANA Health Sciences by 12.3% in the fourth quarter. First Quadrant L P CA now owns 22,659 shares of the company’s stock worth $1,678,000 after purchasing an additional 2,475 shares during the period. Acadian Asset Management LLC boosted its position in shares of USANA Health Sciences by 1,867.2% in the fourth quarter. Acadian Asset Management LLC now owns 131,981 shares of the company’s stock worth $9,774,000 after purchasing an additional 125,272 shares during the period. Creative Planning bought a new position in shares of USANA Health Sciences in the fourth quarter worth approximately $219,000. Hikari Power Ltd bought a new position in shares of USANA Health Sciences in the fourth quarter worth approximately $255,000. Finally, Public Employees Retirement System of Ohio boosted its position in shares of USANA Health Sciences by 20.2% in the third quarter. Public Employees Retirement System of Ohio now owns 13,103 shares of the company’s stock worth $756,000 after purchasing an additional 2,206 shares during the period. 44.26% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences, Inc. (NYSE USNA) opened at $76.00 on Friday. The firm has a market cap of $1,820.00, a P/E ratio of 30.28 and a beta of 0.99. USANA Health Sciences, Inc. has a 12-month low of $52.55 and a 12-month high of $79.00.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.11 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.11. The business had revenue of $273.11 million during the quarter, compared to analyst estimates of $258.67 million. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.02%. The company’s revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.87 earnings per share. equities analysts expect that USANA Health Sciences, Inc. will post 4.25 EPS for the current fiscal year.

In related news, Director Myron W. Wentz sold 164,916 shares of the company’s stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $66.40, for a total transaction of $10,950,422.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Global Ltd Gull sold 7,289 shares of the company’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $66.01, for a total transaction of $481,146.89. Following the transaction, the insider now owns 11,996,192 shares of the company’s stock, valued at approximately $791,868,633.92. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 433,455 shares of company stock valued at $28,990,246. 53.20% of the stock is owned by company insiders.

A number of equities analysts have weighed in on the stock. Sidoti lowered shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a research report on Wednesday, January 24th. Pivotal Research upped their price target on shares of USANA Health Sciences from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday. TheStreet lowered shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a research report on Tuesday. Finally, BidaskClub upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Thursday, October 26th.

ILLEGAL ACTIVITY WARNING: This piece was first published by Daily Political and is the property of of Daily Political. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.dailypolitical.com/2018/02/10/bessemer-group-inc-trims-holdings-in-usana-health-sciences-inc-usna.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.